Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (2)
Type
(
1 selected
)
Type
Guidance (708)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (221)
COVID-19 rapid guidelines (5)
Diagnostics guidance (47)
Health technology evaluations (9)
Highly specialised technologies guidance (24)
Interventional procedures guidance (587)
Medical technologies guidance (65)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (72)
Technology appraisal guidance (708)
Apply filters
Showing 1 to 10 of 708
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy
TA913
6 September 2023
6 September 2023
Semaglutide for managing overweight and obesity
TA875
8 March 2023
4 September 2023
Cipaglucosidase alfa with miglustat for treating late-onset Pompe disease
TA912
15 August 2023
15 August 2023
Selpercatinib for untreated RET fusion-positive advanced non-small-cell lung cancer
TA911
26 July 2023
26 July 2023
Semaglutide for managing overweight and obesity in young people aged 12 to 17 years (terminated appraisal)
TA910
13 July 2023
13 July 2023
Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer
TA909
12 July 2023
12 July 2023
Rimegepant for preventing migraine
TA906
5 July 2023
5 July 2023
Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy
TA908
5 July 2023
5 July 2023
Deucravacitinib for treating moderate to severe plaque psoriasis
TA907
28 June 2023
28 June 2023
Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19
TA878
29 March 2023
22 June 2023
Current page
1
2
3
…
71
Page
1
of
71
Next page
Results per page
10
25
50
All
Back to top